Celltrion Q1 net soars on strong sales of biosimilars

SEOUL, May 9 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its first-quarter net profit more than quintupled from a year earlier on strong sales of its biosim